Percutaneous coronary intervention and the use of glycoprotein IIb/IIIa inhibitors in patients with chronic kidney disease on dialysis: A single center experience

Hemodialysis International

Volumn 12, Issue SUPPL. 2, 2008, Pages

  Khaja, Azam ^a,b   Garg, Rajeev ^a   Govindarajan, Gurushanker ^a   Madsen, Richard ^a   Aggarwal, Kul ^a  

^a University of Missouri   (United States)

^b NONE   (United States)

Author keywords

Coronary artery disease; Diabetes mellitus; Dialysis; Direct thrombin inhibitors; Glycoprotein IIb IIIa inhibitors; Percutaneous coronary intervention

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; HIRULOG;

ADULT; ANGIOPLASTY; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OFF LABEL DRUG USE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERITONEAL DIALYSIS; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDY; TREATMENT FAILURE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ANTITHROMBINS; COMBINED MODALITY THERAPY; CORONARY ARTERY DISEASE; FEMALE; HIRUDINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECOMBINANT PROTEINS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 53349171327     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00316.x     Document Type: Conference Paper

References (27)

1. Collins AJ, Kasiske B, Herzog C, et al. United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis. 2007;49(Suppl 1):A6-7, S1-S296.
2. Levey AS, Beto JA, Coronado BE, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease. Am J Kidney Dis. 1998; 32:853-906.
3. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA. Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int. 2003; (Suppl 87):S24-S31.
4. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med. 1998; 339:799-805.
5. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med. 1994; 330:956-961.
6. EPILOG Investigators. Platelet Glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997; 336:1689-1696.
7. EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet. 1998; 352:87-92.
8. The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with Tirofiban in unstable angina and non-Q-wave myocardial infarction. The platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms (PRISM-PLUS) study investigators. N Engl J Med. 1998; 338:1488-1497.
9. Franga DL, Kratz JM, Crumbley AJ, Zellner JL, Stroud MR, Crawford FA. Early and long-term results of coronary artery bypass grafting in dialysis patients. Ann Thorac Surg. 2000; 70:813-818, discussion 819.
10. Karvouni E, Katritsis DG, Ioannidis JPA. Intravenous glycoprotein IIb/ IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol. 2003; 41:26-32.
11. Smith SC Jr., Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/SCAI writing committee to update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2006; 47:216-235.
12. Lindner A, Charra B, Sherrand DJ, Scribner B. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974; 290:697-701.
13. McCullough PA. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? J Am Coll Cardiol. 2003; 41:725-728.
14. Naidu SS, Selzer F, Jacobs A, et al. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol. 2003; 92:1160-1164.
15. Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B. Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant. 1997; 12:1187-1191.
16. Herzog C. Is there something special about ischemic heart disease in patients undergoing dialysis? Am Heart J. 2004; 147:942-944.
17. Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis. 1995; 25:281-290.
18. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J. 1990; 119(3 Pt 1):484-489.
19. Reusser LM, Osborn LA, White HJ, Sexson R, Crawford MH. Increased morbidity after coronary angioplasty in patients on chronic hemodialysis. Am J Cardiol. 1994; 73:965-967.
20. Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures. Kidney Int. 1999; 56:324-332.
21. Ahmed WH, Shubrooks SJ, Gibson CM, Baim DS, Bittl JA. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J. 1994; 128:252-255.
22. Le Feuvre C, Borentain M, Beygui F, Helft G, Batisse JP, Metzger JP. Comparison of short- and long-term outcomes of coronary angioplasty in patients with and without diabetes mellitus and with and without hemodialysis. Am J Cardiol. 2003; 92:721-725.
23. Azar RR, Prpic R, Ho KK, et al. Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol. 2000; 86:485-489.
24. Le Feuvre C, Dambrin G, Helft G, et al. Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. Am J Cardiol. 2000; 85:1365-1368.
25. Kuchulakanti PK, Torguson R, Chu WW, et al. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2006; 97:792-797, Epub 2006 Jan 18.
26. Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2002; 39:1113-1119.
27. Hassani SE, Chu WW, Wolfram RM, et al. Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol. 2006; 18:273-277.